(Q44384126)

2 December 2017

title

Target-mediated drug disposition model and its approximations for antibody-drug conjugates (English)

1 reference

2 December 2017

1 reference

Leonid Gibiansky

1

1 reference

2 December 2017

Ekaterina Gibiansky

series ordinal

2

1 reference

2 December 2017

publication date

11 December 2013

1 reference

Journal of Pharmacokinetics and Pharmacodynamics

2 December 2017

published in

1 reference

2 December 2017

volume

41

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

35-47

1 reference

https://scigraph.springernature.com/pub.10.1007/s10928-013-9344-y

2 December 2017

exact match

0 references

cites work

Maturing antibody-drug conjugate pipeline hits 30.

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9344-Y

An integrated multiple-analyte pharmacokinetic model to characterize trastuzumab emtansine (T-DM1) clearance pathways and to evaluate reduced pharmacokinetic sampling in patients with HER2-positive metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9344-Y

Semi-mechanistic population pharmacokinetic model of multivalent trastuzumab emtansine in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9344-Y

General pharmacokinetic model for drugs exhibiting target-mediated drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9344-Y

Quasi-equilibrium pharmacokinetic model for drugs exhibiting target-mediated drug disposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9344-Y

Approximations of the target-mediated drug disposition model and identifiability of model parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9344-Y

Target-mediated drug disposition model: approximations, identifiability of model parameters and applications to the population pharmacokinetic-pharmacodynamic modeling of biologics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9344-Y

Selection between Michaelis-Menten and target-mediated drug disposition pharmacokinetic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-013-9344-Y

Pharmacokinetic considerations for antibody drug conjugates

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24322877

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10928-013-9344-Y

1 reference

2 December 2017

1 reference